🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label study to evaluate the drug-drug interaction p...
Status
Completed
Location
PRA Health Sciences (PRA) - Early Development Services (EDS)
Start Date
2019-11-12
Trial ID
NCT04166669
Treatments Being Tested
This is a Phase l double-blind, placebo-controlled, randomized study to inv...
Status
Completed
Location
PRA Health Sciences (PRA) - Early Development Services (EDS)
Start Date
2016-10-31
Trial ID
NCT02957929
Treatments Being Tested
First In Human (FIH), randomized, double-blind, placebo-controlled single a...
Status
Completed
Location
PRA Health Sciences
Start Date
2016-05-24
Trial ID
NCT02956499
This is a multicenter, open-label, single arm study to evaluate the efficac...
Status
Completed
Location
Netcare Union Hospital Trauma Surgeons
Start Date
2019-12-13
Trial ID
NCT04148287
Treatments Being Tested
This is a single-center, open-label, non-randomized, single dose study in h...
Status
Completed
Location
Quotient Sciences
Start Date
2018-08-17
Trial ID
NCT04804059
Treatments Being Tested
An open-label, multi-center, Phase Ib study to determine the safety and pha...
Status
Completed
Location
University of Cologne, Center for Integrated Oncology (CIO)
Start Date
2017-11-27
Trial ID
NCT03333005
Treatments Being Tested
A study to learn about the bioequivalence (the biochemical similarity of tw...
Status
Completed
Location
Pharmaceuticals Research Associates, Inc
Start Date
2021-03-02
Trial ID
NCT05491733
The primary purpose of this open-label study is to characterize the plasma ...
Status
Completed
Location
Inland Empire Liver Foundation
Start Date
2022-10-31
Trial ID
NCT05582187
Treatments Being Tested
This is a multicenter, open-label, non-comparative, single-arm study to eva...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine
Start Date
2018-10-03
Trial ID
NCT03604705
Treatments Being Tested
This is a Phase 2, multicenter study to evaluate APX001 for the treatment o...
Status
Terminated
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2020-01-04
Trial ID
NCT04240886
Treatments Being Tested